Publications by authors named "Tristan Knight"

Claim this Profile
I
Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults with Acute Myeloid Leukemia: A CIBMTR Report.
Hemalatha G Rangarajan, Deepakbabu Chellapandian, Rasha Atshan, Kwang Woo Ahn, Sarthak Kumar, Tristan E Knight

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to <[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>.
Melissa R Hines, Tristan E Knight, Kevin O McNerney, Mark B Leick, Tania Jain

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STIM1-mediated NFAT signaling synergizes with STAT1 to control T-bet expression and T1 differentiation.
Li Zhong, Yin-Hu Wang, Sascha Kahlfuss, Miki Jishage, Maxwell McDermott, Tristan E Knight

Nat Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma?
Tristan E Knight, Larisa Broglie, Akshay Sharma, Muna Qayed, Gregory A Yanik

Pediatr Hematol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Olalekan O Oluwole, Bhagirathbhai Dholaria, Tristan E Knight, Tania Jain, Frederick L Locke

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No impact of CD34 cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, Rasha Atshan, Donna A Wall

Bone Marrow Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Melissa R Hines, Tristan E Knight, Kevin O McNerney, Mark B Leick, Tania Jain

Transplant Cell Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Autograft CD34 Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors.
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, Rasha Atshan, Donna A Wall

Transplant Cell Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"FLipping" the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors.
Tristan E Knight, Holly Edwards, Soheil Meshinchi, Jeffrey W Taub, Yubin Ge

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell Therapy.
Tania Jain, Tristan Knight, Maritza C Alencar, Laurie Davis, Kamakshi Rao

Transplant Cell Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation in an adolescent with Prader-Willi syndrome - unique considerations.
Tristan E Knight, Jane Lowry, Sarah Leppington, Donna A Wall, Jennifer Seelisch

Pediatr Hematol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant Peripheral Nerve Sheath Tumors-A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management.
Samantha W E Knight, Tristan E Knight, Teresa Santiago, Andrew J Murphy, Abdelhafeez H Abdelhafeez

Children (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3-ITD AML.
Tristan E Knight, Yubin Ge, Jeffrey W Taub, Johann Hitzler, Joerg Krueger

Pediatr Blood Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAP4K1 expression is a novel resistance mechanism and independent prognostic marker in AML-but can be overcome via targeted inhibition.
Tristan E Knight, Holly Edwards, Jeffrey W Taub, Yubin Ge

EBioMedicine· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML.
Xinan Qiao, Jun Ma, Tristan Knight, Yongwei Su, Holly Edwards

Blood Cancer J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia.
Xinyu Li, Yongwei Su, Katie Hege, Gerard Madlambayan, Holly Edwards, Tristan Knight

Haematologica· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia.
Tingting Wang, Margaret Shatara, Fangbing Liu, Tristan Knight, Holly Edwards

Signal Transduct Target Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer.
Tristan E Knight

Biopreserv Biobank· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyspnea in a Splenectomized 12-year-old Male with Hereditary Spherocytosis.
Tristan Knight, Andrea Bedway Wait, Madhvi Rajpurkar

Pediatr Rev· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridium difficile infection in a children's hospital with specific patterns among pediatric oncology and hematopoietic stem cell transplantation populations.
Jessica L Spruit, Tristan Knight, Colleen Sweeney, Hossein Salimnia, Süreyya Savaşan

Pediatr Hematol Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia.
Jun Ma, Shoujing Zhao, Xinan Qiao, Tristan Knight, Holly Edwards

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild erythrocytosis as a presenting manifestation of associated erythrocyte volume disorders.
Tristan Knight, Ahmar Urooj Zaidi, Shengnan Wu, Manisha Gadgeel, Steven Buck

Pediatr Hematol Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Management of Pleuropulmonary Blastoma: A Surgical Perspective.
Samantha Knight, Tristan Knight, Amir Khan, Andrew J Murphy

Children (Basel)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.
Fangbing Liu, Tristan Knight, Yongwei Su, Holly Edwards, Guan Wang

Target Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemia.
Tristan Knight, Holly Edwards, Jeffrey W Taub, Yubin Ge

Cancer Manag Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis